Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2019 | 2 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy.
Clin Cancer Res. 2020 Jan 1;26(1):232-241. doi: 10.1158/1078-0432.CCR-19-2234. Epub 2019 Oct 17.
Clin Cancer Res. 2020.
PMID: 31624103
Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity.
Mut M, Adiguzel Z, Cakir-Aktas C, Hanalioğlu Ş, Gungor-Topcu G, Kiyga E, Isikay I, Sarac A, Soylemezoglu F, Strobel T, Ampudia-Mesias E, Cameron C, Aslan T, Tekirdas E, Hayran M, Oguz KK, Henzler C, Saydam N, Saydam O.
Mut M, et al. Among authors: ampudia mesias e.
Cancers (Basel). 2023 Jul 26;15(15):3782. doi: 10.3390/cancers15153782.
Cancers (Basel). 2023.
PMID: 37568598
Free PMC article.
Item in Clipboard
SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma.
Ampudia-Mesias E, El-Hadad S, Cameron CS, Wöhrer A, Ströbel T, Saydam N, Saydam O.
Ampudia-Mesias E, et al.
Cancers (Basel). 2022 Apr 14;14(8):1984. doi: 10.3390/cancers14081984.
Cancers (Basel). 2022.
PMID: 35454889
Free PMC article.
Item in Clipboard
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.
Ampudia-Mesias E, Puerta-Martinez F, Bridges M, Zellmer D, Janeiro A, Strokes M, Sham YY, Taher A, Castro MG, Moertel CL, Pluhar GE, Olin MR.
Ampudia-Mesias E, et al.
Neurotherapeutics. 2021 Jul;18(3):1980-1994. doi: 10.1007/s13311-021-01038-1. Epub 2021 Apr 7.
Neurotherapeutics. 2021.
PMID: 33829411
Free PMC article.
Item in Clipboard
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.
Xiong Z, Ampudia-Mesias E, Shaver R, Horbinski CM, Moertel CL, Olin MR.
Xiong Z, et al. Among authors: ampudia mesias e.
Immunotherapy. 2016 Sep;8(9):1059-71. doi: 10.2217/imt-2016-0033.
Immunotherapy. 2016.
PMID: 27485078
Free PMC article.
Item in Clipboard
Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.
Ampudia-Mesias E, Puerta-Martinez F, Bridges M, Zellmer D, Janeiro A, Strokes M, Sham YY, Taher A, Castro MG, Moertel CL, Pluhar GE, Olin MR.
Ampudia-Mesias E, et al.
Neurotherapeutics. 2021 Jul;18(3):2131. doi: 10.1007/s13311-021-01062-1.
Neurotherapeutics. 2021.
PMID: 33929711
Free PMC article.
No abstract available.
Item in Clipboard
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.
Olin MR, Ampudia-Mesias E, Pennell CA, Sarver A, Chen CC, Moertel CL, Hunt MA, Pluhar GE.
Olin MR, et al. Among authors: ampudia mesias e.
Cancers (Basel). 2019 Jan 24;11(2):137. doi: 10.3390/cancers11020137.
Cancers (Basel). 2019.
PMID: 30682795
Free PMC article.
Item in Clipboard
Cite
Cite